FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

74,257 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 0
R2B: 0
R3: 8,449
R4: 41,188
R4B: 11,138
R5: 12,550
R6: 932

By Realm

none: 4,117
au: 300
be: 602
ca: 466
ch: 1,715
cl: 560
cr: 117
cz: 975
de: 7
dk: 99
ee: 73
eu: 805
fi: 87
fr: 202
in: 29
it: 116
kr: 30
nl: 1,019
no: 26
nz: 91
pl: 258
pt: 50
se: 23
stt: 116
uk: 6
us: 20,143
uv: 42,081
vn: 108
other: 6

Start Prev Rows 37000 - 37200 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.93.json	Recommendations Related to Medication Regimen, Change Medication Dose	active	2017-08	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.94.json	Recommendations Related to Medication Regimen, Change Medication Dosage Form	active	2017-08	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.95.json	Recommendations Related to Medication Regimen, Change Medication Course	active	2017-08	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.97.json	Recommendations Related to Medication Regimen, Change Medication Dosing Interval	active	2017-08	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.98.json	Recommendations Related to Medication Regimen, Discontinue Medication	active	2017-08	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1096.99.json	Recommendations Related to Medication Regimen, Monitoring	active	2021-03	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.12.json	Medication Route	active	2024-06	us	9
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.24.json	Extended Pregnancy Status	active	2023-07	us	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.33.json	External Cause of Injury/Morbidity	active	2025-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.35.json	Arthritis Feedback Types (SNOMED)	active	2019-12	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.36.json	Arthritis Feedback Types (LOINC)	active	2025-05	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.45.json	Bidirectional Services eReferral Type	active	2025-05	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.46.json	Bidirectional Services eReferral Reason	active	2025-05	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.50.json	Transport vehicle type	active	2024-08	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.54.json	Specimen type	active	2024-06	us	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.55.json	At Home In Vitro Patient Questions	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1099.58.json	Acute COVID 19 Diagnosis	active	2023-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1102.1.json	Case Management for Behavioral Health	active	2021-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1102.63.json	Case Management for Behavioral Health	active	2021-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1102.64.json	Case Management for Behavioral Health	active	2021-12	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.124.json	Follow Up Within 6 Months	active	2024-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.125.json	Follow Up Within 6 Months	active	2024-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.126.json	Bone Scan	active	2024-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.127.json	Bone Scan	active	2024-01	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.15.json	Hospice Care Ambulatory	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.175.json	Office and Wellness Visits for General Screening	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.176.json	Office and Wellness Visits for General Screening	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.177.json	Office and Wellness Visits for General Screening	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.178.json	Office and Wellness Visits for General Screening	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.28.json	Non Acute Encounter Codes CPT	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.29.json	Non Acute Encounter Codes HCPCS	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.31.json	Bleeding Event Diagnosis Codes ICD9	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.78.json	Statin Associated Muscle Symptoms	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.84.json	Statin Associated Muscle Symptoms	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.85.json	Statin Associated Muscle Symptoms	active	2024-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1108.99.json	Underweight	active	2022-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.11.json	Cornual Ectopic Pregnancy	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.12.json	Cornual Ectopic Pregnancy	active	2021-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.13.json	Perforation of Uterus	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.14.json	Perforation of Uterus	active	2021-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.15.json	Uterine Rupture	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.16.json	Uterine Rupture	active	2021-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.17.json	Transabdominal Cerclage	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.18.json	Transabdominal Cerclage	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.2.json	Transabdominal Cerclage	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.21.json	Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival	active	2021-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.23.json	Intensive Care Unit	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.24.json	Uterine Horn	active	2021-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.25.json	Metroplasty	active	2021-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.3.json	Medical Induction of Labor	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.35.json	Placenta Previa	active	2021-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.36.json	Placenta Accreta Spectrum Previa or Vasa Previa	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.37.json	Placenta Accreta Spectrum Previa or Vasa Previa	active	2023-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.38.json	Outpatient Surgery Service	active	2019-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.41.json	Statin Allergen	active	2022-02	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.42.json	Statin Allergen	active	2021-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.50.json	Rivaroxaban for VTE Prophylaxis	active	2022-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.51.json	Prasugrel	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.52.json	Pharmacological Contraindications For Antithrombotic Therapy	active	2022-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.53.json	Acute Renal Failure	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.54.json	Total Parenteral Nutrition	active	2021-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.55.json	Intravenous Thrombolytic tPA Therapy	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.56.json	Intraarterial Thrombolytic tPA Therapy	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.57.json	Ischemic Stroke Thrombosis	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.58.json	Ischemic Stroke Thrombosis	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.59.json	Ischemic Stroke Other	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.60.json	Ischemic Stroke Other	active	2021-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.61.json	Antithrombotic Therapy Antiplatelet	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.62.json	Antithrombotic Therapy for Ischemic Stroke	active	2021-04	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.63.json	Present On Admission is Yes or Exempt	active	2022-01	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.64.json	Application of Venous Foot Pumps	active	2022-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.65.json	Application of Intermittent Pneumatic Compression Devices	active	2022-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.66.json	Application of Graduated Compression Stockings	active	2022-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.67.json	20 to 42 Plus Weeks Gestation	active	2023-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.68.json	37 to 42 Plus Weeks Gestation	active	2023-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.69.json	37 to 38 Weeks Gestation	active	2023-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.70.json	20 to 42 Plus Weeks Gestation	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.71.json	20 to 42 Plus Weeks Gestation	active	2025-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.72.json	37 to 42 Plus Weeks Gestation	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.73.json	37 to 42 Plus Weeks Gestation	active	2023-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.74.json	37 to 38 Weeks Gestation	active	2023-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.75.json	37 to 38 Weeks Gestation	active	2023-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.76.json	History of Atrial Ablation	active	2022-11	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.77.json	Placenta Accreta Spectrum Previa or Vasa Previa	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1110.78.json	Placenta Previa	active	2023-11	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.143.json	Observation Services	active	2021-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.159.json	All Primary and Secondary Cancer	active	2023-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.161.json	All Primary and Secondary Cancer	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.163.json	Emergency Department Evaluation	active	2020-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.164.json	Admit Inpatient	active	2021-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.171.json	Opioid Use Disorder	active	2024-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.173.json	Sickle Cell Disease with and without Crisis SNOMED	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.174.json	Sickle Cell Disease with and without Crisis ICD	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.175.json	Sickle Cell Disease with and without Crisis	active	2024-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.176.json	Opioid Medication Assisted Treatment (MAT) HCPCS	active	2024-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.177.json	Opioid Medication Assisted Treatment (MAT)	active	2025-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.178.json	Cancer Related Pain ICD 10	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.179.json	Cancer Related Pain SNOMED	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1111.180.json	Cancer Related Pain	active	2024-02	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.10.json	Care Experience Preferences at End of Life LOINC	active	2024-02	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.12.json	Healthcare Agent Ordinality	active	2020-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.14.json	ADIClauseTypeVS	active	2022-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.17.json	Preconditions for Treatment Preferences	active	2024-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.22.json	Advance Directive Document Types	active	2024-07	us	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.23.json	AD Conditions and Prognosis Scenarios	active	2023-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.26.json	Healthcare Agent or Advisor Indicator	active	2024-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.27.json	Initial Treatment portable medical order options	active	2024-08	us	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.28.json	Cardiopulmonary Resuscitation Order Options	active	2024-09	us	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.30.json	Cardiopulmonary Resuscitation Order Procedures	active	2024-08	us	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.31.json	Cardiopulmonary Resuscitation Procedures Grouping	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.32.json	Additional Portable Medical Order Procedures	active	2025-04	us	6
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.33.json	Initial Treatment Portable Medical Order Procedures Grouping	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.34.json	Additional portable medical order Procedures Grouping	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.35.json	Medically Assisted Nutrition Order Options	active	2024-09	us	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.36.json	Medically Assisted Nutrition Portable Medical Order Procedures Grouping	active	2024-09	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.37.json	Healthcare Agent Powers	active	2024-11	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.38.json	Personal Health Goal Options LOINC	active	2025-03	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.40.json	Portable Medical Order Document Types	active	2025-04	us	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.41.json	Advance Healthcare Directive Document Types Grouper	active	2025-04	us	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1115.8.json	Treatment Intervention Preferences at End of Life LOINC	active	2025-04	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.1.json	Rituximab Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.100.json	Pathological M Stage M1c	active	2024-08	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.101.json	Pathological N Stage N3	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.102.json	N Stage pN1a	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.103.json	N Stage pN1b	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.105.json	Pathological N Stage pN1mi	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.106.json	Pathological N Stage N2b	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.107.json	Pathological N Stage N2a	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.108.json	Pathological N Stage N2	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.109.json	Pathological N Stage N1b	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.110.json	Pathological N Stage N1a	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.112.json	Pathological N Stage N0	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.114.json	Pathological T Stage T4d	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.115.json	Pathological T Stage T4c	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.116.json	Pathological T Stage T4b	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.117.json	Pathological T Stage T4a	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.118.json	Pathological T Stage T4	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.120.json	N Stage N2C	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.121.json	T Stage T3c	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.122.json	T Stage T3b	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.123.json	T Stage T3a	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.124.json	Pathological T Stage T3	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.125.json	T Stage T2c	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.126.json	T Stage T2b	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.127.json	T Stage T2a	active	2024-06	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.128.json	Pathological T Stage T2	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.129.json	Pathological T Stage T1c	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.132.json	Pathological T Stage T1b	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.135.json	Pathological T Stage T1a	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.136.json	Pathological T Stage T1	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.137.json	Pathological T Stage T1mic	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.139.json	Pathological T Stage T0	active	2024-08	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.142.json	Cancer Stage III	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.143.json	Cancer Stage IIIA	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.144.json	Cancer Stage IIIB	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.145.json	Cancer Stage IIIC	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.146.json	Cancer Stage IV	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.147.json	Cancer Stage IVA	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.148.json	Cancer Stage IVB	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.149.json	Cancer Stage IVC	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.151.json	Cisplatin Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.153.json	Vinorelbine Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.154.json	Gemcitabine Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.155.json	Docetaxel	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.156.json	Pemetrexed Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.158.json	Vinblastine Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.160.json	ECOG Performance Status	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.161.json	ECOG Performance Status	active	2020-10	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.162.json	ECOG Performance Status	active	2022-03	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.164.json	Karnofsky Performance Status	active	2024-07	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.165.json	Carboplatin Injectable	active	2020-09	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.166.json	Paclitaxel	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.168.json	Doxorubicin Injectable	active	2022-09	us	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.169.json	Irinotecan Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.179.json	Bevacizumab Injectable	active	2024-12	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.181.json	Methotrexate	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.184.json	Breast Cancer	active	2022-06	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.185.json	Breast Cancer	active	2023-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.191.json	Cancer Stage II	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.192.json	Cancer Stage IIA	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.193.json	Cancer Stage IIB	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.194.json	Pertuzumab Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.196.json	Ixabepilone Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.197.json	Goserelin	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.200.json	Epirubicin Injectable	active	2024-12	us	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.202.json	Ramucirumab Injectable	active	2024-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.204.json	Letrozole	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.206.json	Exemestane	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.209.json	Fluorouracil	active	2024-09	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.210.json	Capecitabine Oral	active	2024-12	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.222.json	Aprepitant Oral	active	2024-12	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.223.json	Fosaprepitant Injectable	active	2024-12	us	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.255.json	Colorectal Cancer	active	2021-12	us	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.256.json	Colorectal Cancer	active	2021-12	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.257.json	Colorectal Cancer Chemotherapy	active	2023-12	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.280.json	Cancer Stage IA	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.281.json	Cancer Stage IB	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.286.json	Cancer Stage IIC	active	2024-07	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.291.json	Positive Result	active	2024-12	us
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1116.292.json	Negative Result	active	2015-12	us	1